Bioalpha Holdings Bhd
Bioalpha Holdings Berhad, an investment holding company, manufactures and sells health supplement products in Malaysia, China, and internationally. It operates through Trading and Manufacturing segments. The company also engages in the provision of advertising and promotion services for health supplements, nutrition products, personal care, functional food, and healthcare products; import, export… Read more
Bioalpha Holdings Bhd (0179) - Total Liabilities
Latest total liabilities as of September 2025: RM13.51 Million MYR
Based on the latest financial reports, Bioalpha Holdings Bhd (0179) has total liabilities worth RM13.51 Million MYR as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Bioalpha Holdings Bhd - Total Liabilities Trend (2015–2024)
This chart illustrates how Bioalpha Holdings Bhd's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Bioalpha Holdings Bhd Competitors by Total Liabilities
The table below lists competitors of Bioalpha Holdings Bhd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Ttbio Corp.
TWO:6493
|
Taiwan | NT$354.31 Million |
|
HB Global Ltd
KLSE:5187
|
Malaysia | RM58.38 Million |
|
RFG Holdings Ltd
JSE:RFG
|
South Africa | ZAC2.14 Billion |
|
Universal Ibogaine Inc
PINK:IBOGF
|
USA | $3.73 Million |
|
Gromutual Bhd
KLSE:9962
|
Malaysia | RM116.08 Million |
|
Matinas BioPharma Holdings Inc
NYSE MKT:MTNB
|
USA | $3.23 Million |
|
Sonim Technologies Inc
NASDAQ:SONM
|
USA | $40.92 Million |
|
Tego Cyber Inc
PINK:TGCB
|
USA | $2.60 Million |
Liability Composition Analysis (2015–2024)
This chart breaks down Bioalpha Holdings Bhd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 3.33 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.17 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.15 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Bioalpha Holdings Bhd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Bioalpha Holdings Bhd (2015–2024)
The table below shows the annual total liabilities of Bioalpha Holdings Bhd from 2015 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | RM20.65 Million | -42.42% |
| 2023-12-31 | RM35.86 Million | +9.35% |
| 2022-12-31 | RM32.79 Million | +6.50% |
| 2021-12-31 | RM30.79 Million | +17.40% |
| 2020-12-31 | RM26.23 Million | -7.36% |
| 2019-12-31 | RM28.31 Million | +32.74% |
| 2018-12-31 | RM21.33 Million | +16.02% |
| 2017-12-31 | RM18.38 Million | +15.94% |
| 2016-12-31 | RM15.85 Million | +63.56% |
| 2015-12-31 | RM9.69 Million | -- |